Dr Matthew Streetly is a Consultant Haematologist at Guy's and St Thomas' NHS Foundation Trust. He was appointed as the clinical lead for myeloma and plasma cell disorders in 2010. Dr Streetly is also a key member of the haemato-oncology inpatient attending team, where he provides expert care for patients with myeloma, lymphoma, and leukaemia.

Dr Streetly has a special interest in the use of novel therapies for myeloma patients. He is the principal investigator on multiple clinical trials, aiming to advance treatment options and improve patient outcomes. His dedication to research and innovation has made him a prominent figure in the field of haematology.

In addition to his clinical and research roles, Dr Streetly is an active member of the UK Myeloma Forum Guidelines Writing Group. He also serves as a special trustee of the British Society of Haematology. His contributions to the field are well-recognised, and he is frequently invited to speak at national and international medical conferences.

Dr Streetly has published extensively on myeloma and related disorders, sharing his expertise and findings with the medical community. His areas of expertise include myeloma diagnostics and biomarkers, haematology, and the treatment of plasma cell disorders such as amyloidosis and MGUS. He is also skilled in performing stem cell transplants and managing lymphoma cases.

Dr Streetly's commitment to patient care, research, and education makes him a highly respected and influential figure in haematology. His work continues to shape the future of myeloma treatment and improve the lives of patients affected by these complex conditions.